InvestSMART

pSivida Corp (ASX: PVA) - Announcements

DELISTED - Current share price for PVA : $2.990

ASX company news and announcements for pSivida Corp (PVA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All pSivida Corp (PVA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than pSivida Corp (PVA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for pSivida Corp (PVA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- pSivida new clinical trial for drug delivery device in AMD 12 Dec 2008 9:42AM n/a $2.990 n/a
- Form 10-Q for the Quarter Ended September 30, 2008 13 Nov 2008 10:41AM $1.450 $2.990 risen by 106.21%
- Appendix 4C - quarterly 12 Nov 2008 11:16AM $1.450 $2.990 risen by 106.21%
- Results from the six-month Human PK Study of Iluvien for DME 2 Oct 2008 9:37AM $1.800 $2.990 risen by 66.11%
- DSMB supports continuation of pSivida phase III trial 26 Sep 2008 9:27AM $2.650 $2.990 risen by 12.83%
- pSivida June 2008 Quarter - Commentary and Highlights 31 Jul 2008 12:48PM $2.910 $2.990 risen by 2.75%
- BrachySil Phase IIb Pancreatic Cancer Trials Commence 7 Jul 2008 9:16AM $2.470 $2.990 risen by 21.05%
- Interim Results from 3 month readout Human PK Medidur Study 27 Jun 2008 10:18AM $2.710 $2.990 risen by 10.33%
- Open Briefing. pSivida. Reincorporation of pSivida to US 20 Jun 2008 11:28AM $2.800 $2.990 risen by 6.79%
- Admission to Official List 11 Jun 2008 1:00PM n/a $2.990 n/a

351 - 360 of 360 results

Page 15 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.